Therapeutic compounds targeting Lipid II for antibacterial purposes

Resistance against commonly used antibiotics has emerged in all bacterial pathogens. In fact, there is no antibiotic currently in clinical use against which resistance has not been reported. In particular, rapidly increasing urbanization in developing nations are sites of major concern. Additionally...

Descripción completa

Detalles Bibliográficos
Autores principales: Malin, Jakob J, de Leeuw, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711568/
https://www.ncbi.nlm.nih.gov/pubmed/31692545
http://dx.doi.org/10.2147/IDR.S215070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711568/
https://www.ncbi.nlm.nih.gov/pubmed/31692545
http://dx.doi.org/10.2147/IDR.S215070

Ejemplares similares